Top Premarket Gainers

MT NewswiresNov 25 07:41 ET

Institutions Along With Private Equity Firms Who Hold Considerable Shares InQ32 Bio Inc. (NASDAQ:QTTB) Come Under Pressure; Lose 17% of Holdings Value

Simply Wall StNov 14 07:56 ET

Positive Outlook for Q32 Bio: Buy Rating Backed by Promising Clinical Timelines and Increased Price Target

TipRanksNov 11 01:30 ET · Ratings

Q32 Bio Advances Clinical Trials Amidst Financial Challenges

TipRanksNov 8 01:14 ET

Q32 Bio Inc Grapples With Internal Control Challenges Amid Compliance Costs

TipRanksNov 8 01:00 ET

Express News | Q32 Bio Inc : Piper Sandler Raises Target Price to $85 From $60

ReutersNov 7 09:14 ET